Ticker > Company >

GKB Ophthalmics share price

GKB Ophthalmics Ltd.

NSE: GKB BSE: 533212 SECTOR: Medical Equipment/Supplies/Accessories  12k   5   1

97.00
+0.22 (0.23%)
BSE: Today, 04:00 PM

Price Summary

Today's High

₹ 103.95

Today's Low

₹ 97

52 Week High

₹ 136.4

52 Week Low

₹ 74.1

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

48.89 Cr.

Enterprise Value

59.27 Cr.

No. of Shares

0.5 Cr.

P/E

0

P/B

2.39

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  40.61

CASH

0.7 Cr.

DEBT

11.08 Cr.

Promoter Holding

50.95 %

EPS (TTM)

₹  -10.21

Sales Growth

12.45%

ROE

-13.27 %

ROCE

-4.83%

Profit Growth

-18.57 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year12.45%
3 Year13.47%
5 Year0.46%

Profit Growth

1 Year-18.57%
3 Year-27.62%
5 Year-5.08%

ROE%

1 Year-13.27%
3 Year-10.18%
5 Year-9.84%

ROCE %

1 Year-4.83%
3 Year-3.63%
5 Year-3.85%

Debt/Equity

0.4619

Price to Cash Flow

35.86

Interest Cover Ratio

-1.119

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 50.95 0.00
Jun 2024 50.95 0.00
Mar 2024 50.93 0.00
Dec 2023 50.88 0.00
Sep 2023 50.86 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -4.25399999999999 days.
  • The company has a high promoter holding of 50.95%.

 Limitations

  • The company has shown a poor profit growth of -27.6167553820991% for the Past 3 years.
  • The company has shown a poor revenue growth of 13.468324813367% for the Past 3 years.
  • Company has a poor ROE of -10.1767384809718% over the past 3 years.
  • Company has a poor ROCE of -3.6271338322902% over the past 3 years
  • Company has low Interest coverage ratio of -1.119.
  • Company has contingent liabilities of 17.2017 Cr.
  • The company has a low EBITDA margin of -3.04785657630779% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 7.27 6.84 7.36 8.62 8.26
Total Expenditure 8.12 7.85 7.76 9.05 9.3
Operating Profit -0.85 -1.01 -0.41 -0.43 -1.04
Other Income 0.07 1.72 0.2 0.09 0.06
Interest 0.38 0.36 0.48 0.41 0.4
Depreciation 0.65 0.66 0.64 0.65 0.66
Exceptional Items 0 0 0 0 0
Profit Before Tax -1.81 -0.31 -1.33 -1.4 -2.04
Tax 0 0 0.04 0.01 0.01
Profit After Tax -1.81 -0.31 -1.37 -1.41 -2.05
Adjusted EPS (Rs) -3.59 -0.62 -2.72 -2.79 -4.07

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 25.56 21.34 27.05 27.73 31.18
Total Expenditure 26.29 21.92 27.49 28.83 32.45
Operating Profit -0.73 -0.57 -0.45 -1.1 -1.27
Other Income 1.38 3.34 1.96 2.09 2.08
Interest 1.35 1.34 1.34 1.5 1.59
Depreciation 3.47 2.99 2.49 2.54 2.59
Exceptional Items 0 -0.72 0 0 0
Profit Before Tax -4.17 -2.29 -2.31 -3.04 -3.38
Tax 0 -0.18 0 -0.16 0.04
Net Profit -4.17 -2.11 -2.31 -2.88 -3.42
Adjusted EPS (Rs.) -8.28 -4.18 -4.58 -5.72 -6.78

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 5.04 5.04 5.04 5.04 5.04
Total Reserves 30.21 27.73 25.36 22.48 18.95
Borrowings 0 1 1.62 1.17 0.64
Other N/C liabilities 4.97 5.72 6.63 6.62 6.99
Current liabilities 20.2 21.11 18.98 17.58 20.51
Total Liabilities 60.42 60.6 57.63 52.89 52.13
Assets
Net Block 24.83 22.28 21.27 17.28 15.89
Capital WIP 0 1.23 3.29 3.82 3.78
Intangible WIP 0 0 0 0 0
Investments 3.2 11.9 11.9 11.9 11.9
Loans & Advances 5.66 6.67 7.08 6.46 6.3
Other N/C Assets 0.09 0.04 0.03 0 0
Current Assets 26.65 18.48 14.06 13.43 14.26
Total Assets 60.42 60.6 57.63 52.89 52.13
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -4.17 -2.29 -2.31 -3.04 -3.38
Adjustment 4.14 2.13 2.25 2.34 2.23
Changes in Assets & Liabilities 6.18 2.27 2.4 -0.41 2.52
Tax Paid -0.01 0 -0.01 -0.04 -0.01
Operating Cash Flow 6.13 2.11 2.33 -1.14 1.36
Investing Cash Flow -5.68 -11.52 -0.83 2.4 0.37
Financing Cash Flow 3.31 0.61 -1.5 -2.03 -1.74
Net Cash Flow 3.76 -8.8 0 -0.78 0

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 50.86 50.88 50.93 50.95 50.95
gaurav gupta 8.09 8.09 8.09 8.09 8.09
krishna gopal gupta 17.86 17.86 17.90 17.90 17.90
krishnagopal gupta and so... 5.73 5.75 5.77 5.78 5.78
shefali chawla 4.81 4.81 4.81 4.81 4.81
veena gupta 5.97 5.97 5.97 5.97 5.97
vikram gupta 8.39 8.39 8.39 8.39 8.39
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 49.14 49.12 49.07 49.05 49.05
brijendra kumar gupta 4.86 4.86 4.86 4.86 4.86
coeus global opportunitie... - - - 1.79 1.79
dhwaja commodity services... 1.43 1.43 1.43 1.43 1.43
jyotivardhan jaipuria 1.32 1.32 1.32 1.32 1.32
kiran rashmin rughani - - - - 1.09
krishna murari gupta 6.49 6.49 6.49 6.43 6.39
lalit kumar gupta 1.40 1.40 1.40 1.40 1.40
mahendra girdharilal wadh... - - - - 1.00
somo vision co. ltd. 3.97 3.97 3.97 3.97 3.97
tanvi jignesh mehta - - - 1.20 1.75
vijit global securities p... - - - - 1.00
usha gupta 1.68 1.68 1.68 1.52 -
polus global fund 1.79 1.79 1.29 - -
umesh chamdia 1.41 1.41 - - -
raviraj developers ltd 1.14 - - - -

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

GKB Ophthalmics - Quaterly Results 13 Aug, 6:51 PM GKB Ophthalmics informs about certificate 6 Jul, 10:25 AM GKB Ophthalmics informs about disclosure 30 Mar, 11:26 AM GKB Ophthalmics - Quaterly Results 14 Feb, 6:36 PM Gkb Ophthalmics informs about certificate 17 Jan, 3:41 PM Gkb Ophthalmics informs about AGM minutes 11 Oct, 1:50 PM GKB Ophthalmics informs about compliances-certificate 13 Jul, 4:21 PM GKB Ophthalmics informs about compliance certificate 19 Apr, 5:15 PM Gkb Ophthalmics informs about outcome of directors meeting 13 Mar, 3:26 PM GKB Ophthalmics informs about newspaper publication 17 Feb, 4:27 PM GKB Ophthalmics informs about disclosure of related party transactions 26 Nov, 2:38 PM GKB Ophthalmics informs about newspaper cuttings 16 Aug, 5:05 PM GKB Ophthalmics informs about board meeting 28 Jul, 4:27 PM GKB Ophthalmics informs about disclosure 14 Jun, 4:12 PM Gkb Ophthalmics informs about disclosure 17 May, 4:48 PM Gkb Ophthalmics informs about outcome of director’s meeting 17 Mar, 5:14 PM Gkb Ophthalmics informs about postal ballot notice 11 Mar, 4:38 PM GKB Ophthalmics informs about related party transactions 8 Dec, 11:53 AM GKB Ophthalmics informs about disclosure 6 Sep, 4:01 PM GKB Ophthalmics informs about book closure 6 Sep, 3:59 PM GKB Ophthalmics informs about disclosure 31 Aug, 2:25 PM GKB Ophthalmics informs about newspaper publication 30 Aug, 1:47 PM GKB Ophthalmics informs about prohibition of insider trading 30 Aug, 1:41 PM GKB Ophthalmics informs about newspaper cuttings 14 Jun, 4:34 PM GKB Ophthalmics informs about disclosure 11 Mar, 3:53 PM GKB Ophthalmics informs about disclosure 9 Mar, 4:24 PM GKB Ophthalmics informs about disclosure 8 Mar, 12:11 PM GKB Ophthalmics informs about disclosure 25 Feb, 3:03 PM GKB Ophthalmics informs about disclosure 19 Feb, 12:55 PM GKB Ophthalmics informs about newspaper publication 1 Feb, 10:49 AM GKB Ophthalmics informs about disclosure 1 Jan, 3:57 PM GKB Ophthalmics informs about disclosure 17 Dec, 3:30 PM GKB Ophthalmics informs about outcome of board meeting 16 Dec, 2:15 PM GKB Ophthalmics informs about postal ballot notice 30 Nov, 3:10 PM GKB Ophthalmics informs about proceedings of the 38th AGM 26 Sep, 2:08 PM GKB Ophthalmics informs about company updates 7 Sep, 3:19 PM GKB Ophthalmics informs about newspaper cuttings 11 Aug, 10:19 AM GKB Ophthalmics informs about prohibition of insider trading 17 Jul, 3:36 PM GKB Ophthalmics informs about newspaper publication 12 Jun, 3:41 PM

GKB Ophthalmics Stock Price Analysis and Quick Research Report. Is GKB Ophthalmics an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. GKB Ophthalmics stock price today is Rs 97. So, let’s look into GKB Ophthalmics and its performance over the period of time. 

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 1.3633 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. GKB Ophthalmics has a Debt to Equity ratio of 0.4619 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In GKB Ophthalmics , the EPS growth was -18.5718 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, GKB Ophthalmics has OPM of -4.08684915251518 % which is a bad sign for profitability.
     
  • ROE: GKB Ophthalmics have a poor ROE of -13.267 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of GKB Ophthalmics is Rs 97. One can use valuation calculators of ticker to know if GKB Ophthalmics share price is undervalued or overvalued.
Last Updated on:
Brief about GKB Ophthalmics
X